Unbalanced risk factors, could compromise the effectiveness of physical training in patients with intermittent claudication?

Minerva Cardioangiologica

Volumn 57, Issue 2, 2009, Pages 165-174

  Leone, A ^b   Laudani, R ^b   Definite, G ^b   Martini, ^a   Andreozzi, G M ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Vascular Rehabilitation Unit   (Italy)

Author keywords

Intermittent claudication; Peripheral vascular arterial diseases; Physical fitness; Rehabilitation

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; TRAINING; TREADMILL EXERCISE; WALKING; WORKLOAD;

EID: 67649598887     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-551 (Pubitemid 15133809)
2. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995;91:1472-1479
3. Selvin E, Erlinger TO. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-743
4. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: A review. J Clin Epidemiol 1992;45:529-542
5. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996;94:3026-3049 (Pubitemid 26411793)
6. Sieminski DJ, Gardner AW. The relationship between daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med 1997;2:286-291 (Pubitemid 28212094)
7. Feinglass J, McCarthy WJ, Slavensky R, Manheim LM, Martin GJ, and Chicago Claudication Outcomes Research Group. Effect of lower extremity blood pressure on physical functioning in patients who have intermittent claudication. J Vasc Surg 1996;24:503-512 (Pubitemid 26346614)
8. TASC Document. Management of Peripheral Arterial Disease (TransAtlantic Inter-Society Consensus). Int Angiol 2000;19 (Suppl 1):1-304.
9. Andreozzi GM, Arosio E, Martini R, Verlato F, Visonà A. Consensus Document on Intermittent Claudication from the Central European Vascular Forum (2nd revision September 2007). Int Angiol 2008;27:93-113.
10. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL. ACC/AHA Guidelines for the management of PAD. JACC 2006;20:1-75.
11. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. TASC II Working Group: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl 1):S1-75. (Pubitemid 46068992)
12. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO et al. for the Cardiovascular Health Study (CHS) Collaborative Research Group. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993;88:837-45.
13. Ricci MA, Fleishman C, Gerstein N. The effects of cigarette smoking and smoking cessation aids on transcutaneous oxygen levels. J Vasc Med Biol 1993;4:256-259 (Pubitemid 24169133)
14. Yataco AR, Gardner AW. Acute reduction in ankle/brachial index following smoking in chronic smokers with peripheral arterial occlusive disease. Angiology 1999;50:355-360 (Pubitemid 29230991)
15. Gardner AW. The effect of cigarette smoking on exercise capacity in patients with intermittent claudication. Vasc Med 1996;1:181-186 (Pubitemid 26402979)
16. Gardner AW, Sieminski DJ, Killewich LA. The effect of cigarette smoking on free-living daily physical activity in older claudication patients. Angiology 1997;48:947-55.
17. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 2004;53:1782. (Pubitemid 38857036)
18. Zimmerman BR, Palumbo PJ, O'Fallon WM, Osmundson PJ, Kazmier FJ. A prospective study of peripheral occlusive arterial disease in diabetes. I. Clinical characteristics of the subjects. Mayo Clin Proc 1981;56:217-222
19. Di Perri T. Le arteriopatie obliteranti periferiche. In: Allegra C, Andreozzi GM, Coccheri S, Di Perri T, editors. Management del paziente arteriopatico. Milano: Excerpta Medica; 2000:65-113.
20. Carlon R, Andreozzi GM, Leone A. L'esercizio fisico nel paziente con arteriopatia obliterante cronica periferica. In: La prescrizione dell'esercizio fisico in ambito cardiologico (Documento Cardiologico di Consenso della Task Force Multisocietaria). Roma: FMSI & SIC-sport (Ed.); 2006.
21. Lindgärde F, Jelnes R, Björkman H, Adielsson G, Kjellström T, Palmquist I et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group. Circulation 1989;80:1549-1556 (Pubitemid 20031683)
22. Spengel F, Clément D, Boccalon H, Liard F, Brown T, Lehert P. Findings of the Naftidrofuryl in quality of life (NIQOL). European study program. Int Angiol 2002;21:20-27
23. De Backer TL, Vander Stichele RH, Bogaert MG. Buflomedil for intermittent claudication. Cochrane Database Syst Rev 2001 (1):CD000988.
24. Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 1998;98:678-686 (Pubitemid 28387495)
25. Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE Jr, Bortey EB et al. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med 1999;159:2041-2050
26. Brevetti G, Perna S, Sabba C, Martone VD, CondorelliM. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol 1995;26:1411-1416
27. Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol 1999;34:1618-1624 (Pubitemid 29528679)
28. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP, and Vascular Clinical Trialists. Clinical trials for claudication: assessment of exercise performance, functional status, and clinical endpoints. Circulation 1995;92:614-21.
29. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA 1995;274:975-980
30. Leone A, Laudani R, Deinite G, Martini R, Andreozzi GM. Effetti dell'esercizio fisico massimale e del training fisico controllato sulla funzione endoteliale di pazienti con claudicazione intermittente. Minerva Cardioangiol 2006;54 (Suppl 1):276-278
31. Andreozzi GM, Leone A, Laudani R, Deinite G, Martini R. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training. Int Angiol 2007;26:12-17 (Pubitemid 46860070)
32. Gardner AW, Katzel LI, Sorkin JD, Killewich LA, Ryan A, Flinn WR et al. Improved functional outcomes following exercise rehabilitation in patients with intermittent claudication. J Gerontol A Biol Sci Med Sci 2000;55A:M570-7.
33. Gardner AW, Katzel LI, Sorkin JD, Bradham DD, Hochberg MC, Flinn WR et al. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc 2001;49:755-62. (Pubitemid 32652468)
34. Gardner AW, Katzel LI, Sorkin JD, Goldberg AP. Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: A randomized controlled trial. J Cardiopulmonary Rehabil 2002;22:192-198 (Pubitemid 35033722)
35. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990;81:602-9. (Pubitemid 20055969)
36. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Circulation 1994;90:1866-1874
37. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996;23:104-115 (Pubitemid 26037967)
38. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997;48:291-300. (Pubitemid 27172999)
39. Robeer GG, Brandsma JW, van den Heuvel SP, Smit B, Oostendorp RAB, Wittens CHA. Exercise therapy for intermittent claudication: a review of the quality of randomised clinical trials and evaluation of predictive factors. Eur J Vasc Endovasc Surg 1998;15:36-43. (Pubitemid 28107984)
40. Andreozzi GM, Leone A, Martini R, Laudani R, Salmistraro G, Deinite G. Effectiveness and costs of a short-course supervised training program in claudicants. Proposal for a shared protocol with aerobic working load. Int Angiol 2008;27:401-407
41. Stering Committee of the Physicians' Healthy Study Research Group. Final report on the aspirin component of the ongoing Physicians' Healthy Study. NEJM 1989;321:129-135
42. Plan and operation of the Third National Health and nutrition Examination Survey. 1988-1994, series I: programs and collection procedures. Vital Health Stat 1 1994;32:1-407.
43. EUROASPIRE Study Group. EUROASPiRE: a European Society of Cardiology survey of secondary prevention of coronary heart disease, principal results. Eur Heart J 1997;18:1569-1582 (Pubitemid 27412412)
44. EUROASPIRE II study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results. Eur Heart J 2001;22:554-572
45. Marzolo M, Verlato F, Zotta L, Guadagnin ML, Borgese L, Cravatari M et al. Occult atherosclerosis and physical vascular examination. A simple strategy to avoid inadequate cardiovascular prevention and under-use of diagnostic vascular guidelines in outpatients. A Multicenter Study in Angiology Care Units in North-Eastern Italy. Int Angiol 2008;27:426-432
46. Ubels FL, Reitsma WD, Links TP, Smit AJ, Sluiter WJ. Walking training for intermittent claudication in diabetes. Diabetes Care 1999;22:198-201. (Pubitemid 29056910)
47. Gardner AW, Killewich LA, Montgomery PS, Katzel LI. Response to exercise rehabilitation in smoking and non-smoking patients with intermittent claudication. J Vasc Surg 2004;39:531-538 (Pubitemid 38298622)
48. Andreozzi GM, Signorelli S, Tornetta D. The rehabilitation in angiology. In: Strano A, Novo S, editors. Advances in vascular pathology. Amsterdam; Elsevier Publishers; 1990. p. 591-597
49. Turton EP, Coughlin PA, Kester RC, Scott DJ. Exercise training reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg 2002;23:309-316 (Pubitemid 41079440)
50. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 1988;260:945-950
51. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80:234-244 (Pubitemid 19195731)